| ¿µ¹® | cohort study | ÇÑ±Û | °èȹ¿¬±¸, ÀüÇ⿬±¸, ¾Õ¹æÇ⿬±¸ |
|---|---|---|---|
| ¼³¸í | ºÐ¼®¿ªÇп¡¼ÀÇ ¿äÀÎ-´ëÁ¶¿¬±¸ÀÇ ÇÑ ±â¹ýÀÌ´Ù. »ç¶÷ÀÇ Áý´Ü¿¡¼ Áúº´À¯Çà°ú °¡¼³¿äÀΰúÀÇ ¿¬°ü¼ºÀ» °íÂûÇÏ¿© Àΰú°ü°è¸¦ ¹àÈ÷´Â °ÍÀ» ¸ñÀûÀ¸·Î ÇÑ´Ù. °¡¼³¿äÀÎÀ» °®´Â Áý´Ü°ú °®Áö ¾Ê´Â Áý´Ü, ȤÀº ÀûÀº Áý´Ü°ú ¸¹Àº Áý´ÜÀÇ 2±º(ÄÚȣƮ)À¸·Î ³ª´©¾î ÃßÀû Á¶»çÇÏ¿© °¢ Áý´Ü¿¡¼ÀÇ Áúº´ÀÇ ¹ß»ýºóµµ¸¦ ºñ±³ÇÏ´Â °ÍÀÌ´Ù. ÀϹÝÀûÀ¸·Î´Â ÀüÇâÀûÀÎ ¿¬±¸·Î ÇàÇØÁö´Â °æ¿ì°¡ ¸¹À¸³ª ÈÄÇâÀûÀÎ ¿¬±¸·Îµµ ÇàÇÏ¿©Áø´Ù. |
||
| ¿µ¹® | quality control | ÇÑ±Û | Á¤µµ°ü¸®, ǰÁú°ü¸®, Áú°ü¸® |
|---|---|---|---|
| ¼³¸í | °úÇÐÀû ¿ø¸®¸¦ ÀÀ¿ëÇÏ¿© Á¦Ç°Ç°ÁúÀÇ À¯Áö-Çâ»óÀ» ±âÇϱâ À§ÇÑ °ü¸®. ³ÐÀº ¶æÀ¸·Î´Â °¡Àå ½ÃÀ强ÀÌ ³ôÀº Á¦Ç°À» °¡Àå °æÁ¦ÀûÀ¸·Î »ý»êÇϱâ À§ÇÑ ÀÏ·ÃÀÇ Ã¼°ÔÀû Á¶Ä¡¸¦ °¡¸®Å°³ª, ÀϹÝÀûÀ¸·Î´Â ¾ÕÀÇ Á¼Àº ¶æÀÇ ÇØ¼®ÀÌ Åë¿ëµÈ´Ù. ÃʱâÀÇ QC´Â ÀüÁ¦Ç°¿¡ ´ëÇØ Ä¡¼ö-Áß·®-üÀûÀ̳ª Àç·áÀÇ ÈÇÐÀû ¼ººÐ µîÀ» ÃøÁ¤Çϰí, ±×°ÍÀ» ¹Ì¸® Á¤ÇØ ³õÀº ǰÁúÇ¥Áذú ºñ±³ÇÏ¿© ÀûºÎ¸¦ ÆÇÁ¤ÇÏ´Â ¹æ¹ýÀÌ ÃëÇØÁ³´Ù. |
||
| ¿µ¹® | infection | ÇÑ±Û | °¨¿° |
|---|---|---|---|
| ¼³¸í | º´¿ø¹Ì»ý¹°ÀÌ »ç¶÷À̳ª µ¿¹° ¶Ç´Â ½Ä¹°ÀÇ Á¶Á÷. ü¾×-Ç¥¸é¿¡ Á¤ÂøÇÏ¿© Áõ½ÄÇÏ´Â »óÅÂ. ÀÌ °æ¿ì µ¿¹° ¶Ç´Â ÀÎü¿¡ ¿©·¯ °¡Áö Áõ»ó, Áï Áúº´À» ÀÏÀ¸Å°´Â °æ¿ì¿Í ÀÏÀ¸Å°Áö ¾Ê´Â °æ¿ì°¡ ÀÖ´Ù. ¿¹¸¦ µé¸é, ÀϺ»³ú¿°¹ÙÀÌ·¯½º°¡ ÀÎü¿¡ ħÀÔÇÏ¿© ü³»¿¡ Áõ½ÄÇÏ¸é ¾î¶² »ç¶÷¿¡°Ô´Â °í¿-µÎÅë-ÀǽÄÀå¾Ö-°æ·Ã µîÀÇ Áõ»óÀÌ ÀϾ ¹ßº´À» ¾ËÁö¸¸, ´ë´Ù¼öÀÇ »ç¶÷Àº ü³»¿¡¼ ¹ÙÀÌ·¯½º°¡ Áõ½ÄÇÏ´õ¶óµµ Áõ¼¼ÀÇ Á¤µµ°¡ ³·°í ¹ß¿À̳ª ±× ¹ÛÀÇ Áõ¼¼µµ ¾ø¾î °¨¿°À» ¸ð¸¥´Ù. ÀÌ¿Í °°ÀÌ º´¿ø¹Ì»ý¹°Àº ÀÎü¿¡ °¨¿°µÇ´õ¶óµµ ¹ßº´ÇÏ´Â °æ¿ì¿Í ÇÏÁö ¾Ê´Â °æ¿ì°¡ ÀÖ´Ù. ÀüÀÚ¸¦ Áõ»ó°¨¿°, ÈÄÀÚ¸¦ ¹«Áõ»ó°¨¿°À̶ó ÇÑ´Ù. °¨¿°ÀÇ ±Ù¿øÀÌ µÇ´Â ȯÀÚ-º¸±ÕÀÚ-°¨¿°µ¿¹°-¸Å°³µ¿¹°-º´¿øÃ¼¸¦ Æ÷ÇÔÇÑ ¹è¼³¹° ¹× ±×¿¡ ÀÇÇØ °¨¿°µÈ °ÍÀ» °¨¿°¿øÀ̶ó Çϰí, ÀÌ·¯ÇÑ °¨¿°¿ø¿¡¼ Á÷Á¢ ¶Ç´Â °£Á¢À¸·Î »ýü¿¡ º´¿øÃ¼°¡ ħÀÔÇÏ´Â °æ·Î¸¦ °¨¿°°æ·Î¶ó ÇÑ´Ù. °¨¿°°æ·Î¿¡´Â °ø±â°¨¿°-Á¢Ã˰¨¿°-°æ±¸°¨¿°-°æÇǰ¨¿° µîÀÌ ÀÖ´Ù. ¶ÇÇÑ °¨¿°ÁõÀº Àü¿°¼º°ú ºñÀü¿°¼ºÀÇ µÎ °¡Áö·Î ³ª´ ¼ö ÀÖ´Ù. ÀüÀÚ´Â Áúº´ÀÇ °æ°ú Áß¿¡(¶§·Î´Â Àẹ±â³ª ȸº¹±â¿¡) °¨¿°ÇÑ »ýüÀÇ ºÐºñ¹° ¶Ç´Â ¹è¼³¹°°ú ÇÔ²² º´¿øÃ¼°¡ ³ª¿Í¼ Á¢ÃË ¶Ç´Â ¸Å°³¿¡ ÀÇÇØ ´Ù¸¥ °³Ã¼¸¦ °¨¿°½ÃŰ´Â °æ¿ì¸¦ ¸»ÇÑ´Ù. ¸¶¸¶-µðÇÁÅ׸®¾Æ-¼ºÈ«¿-Æä½ºÆ®-ÄÝ·¹¶ó-ÀÌÁú µîÀÌ ÀÌ¿¡ ¼ÓÇÑ´Ù. ÈÄÀÚ´Â º´¿øÃ¼°¡ °¨¿°ÇÑ »ýü¿¡¼ ¹è¼³µÇÁö ¾Ê°Å³ª ¹è¼³µÇ´õ¶óµµ ´Ù¸¥ °³Ã¼¿¡´Â °¨¿°À» ÀÏÀ¸Å°Áö ¾Ê´Â °ÍÀ¸·Î ¿©±â¿¡´Â ÆÄ»ódz-¸»¶ó¸®¾Æ-¹ßÁøÆ¼Çª½º-»êÈÄ¿ µîÀÌ ÀÖ´Ù. |
||
| ¿µ¹® | droplet infection | ÇÑ±Û | ºñ¸»°¨¿°, ÀÛÀº¹æ¿ï°¨¿° |
|---|---|---|---|
| ¼³¸í | º¸±ÕÀÚ³ª Áõ»óÀÌ Àִ ȯÀÚ È¤Àº ÀÌ¹Ì °¨¿°µÇ¾î ÀÖ´Â »ç¶÷ÀÇ È£Èí¿¡¼ ³ª¿Â Á÷°æ 10¸¶ÀÌÅ©·Ð ¶Ç´Â ±× ÀÌÇÏÀÇ ¾×üÀÔÀÚ¿¡ ºÎÀ¯Çϰí ÀÖ´Â º´¿øÃ¼ÀÇ ÈíÀÔ¿¡ ÀÇÇÑ È£Èí±â°¨¿°À» À̸¥´Ù. ÀÎÇ÷翣ÀÚ³ª Æíµµ¿°°ú °°ÀÌ È¯ÀÚ°¡ ±âħÀ» Çϰųª ´ëÈ µµÁß¿¡ ÀÚÀßÇÑ ºñ¸»°ú ÇÔ²² º´¿ø±ÕÀÌ °ø±â¿Í ÇÔ²² º´¿ø±ÕÀÌ ¹æÃâµÇ¾î °ø±â¿Í ÇÔ²² È£Èí±â·Î ÈíÀÔµÊÀ¸·Î½á °¨¿°µÇ´Â °ÍÀ» ¸»ÇÑ´Ù. °áÇÙ-À¯Ç༺°¨±â-¹éÀÏÇØ-µðÇÁÅ׸®¾Æ-Æó·Å µîÀÌ ÀÌ¿¡ ÀÇÇÏ¿© ÀüÆÄµÈ´Ù. |
||
| ¿µ¹® | wound infection | ÇÑ±Û | »ó󰨿° |
|---|---|---|---|
| ¼³¸í | Àý¼Õ µîÀÇ ±â°èÀû »óÇØ, ÀÎÀ§Àû ºÎ»ó ¶Ç´Â Ÿ±ÕÀÇ Ä§ÀÔ¿¡ ÀÇÇØ »óó³ Á¶Á÷¿¡¼ ħÀÔÇÏ¿© °¨¿°½ÃŰ´Â °Í. |
||
| SENIC | study of the efficacy of nosocomial infection control |
|---|---|
| CRI | Cardiac Risk Index; catheter-related infection; chronic renal insufficiency; chronic respiratory ins... |
| APIC | Association for Practitioners in Infection Control |
| IC | icteric, icterus; immune complex; immunoconjugate; immunocytochemistry; immunocytotoxicity; impedanc... |
| ICP | incubation period; indwelling catheter program; infantile cerebral palsy; infection-control practiti... |
| SENIC | Study of the Efficacy of Nosocomial Infection Control |
|---|---|
| HICPAC | Hospital Infection Control Practice Advisory Committee |
| ICP | Infection Control Practitioner |
| IC | Infection control |
| ICN | infection control nurse |
| case-control study | <epidemiology> A study in which the risk factors of people with a disease are compared with those without a disease. It is an epidemiological method that begins by identifying persons with the disease or condition of interest (the cases) and compares their past history of exposure to identified or suspected risk factors with the past history of similar exposures among persons who resemble the cases but do not have the disease or condition of interest (the controls). The relationship of an attribute to the disease can therefore be examined by comparing affected and non-affected individuals with regard to the frequency or levels of the attribute in each group. (05 May 2002) |
|---|---|
| infection control | Programs of disease surveillance, generally within health care facilities, designed to investigate, prevent, and control the spread of infections and their causative microorganisms. (12 Dec 1998) |
| infection control, dental | Efforts to prevent and control the spread of infections within dental health facilities or those involving provision of dental care. (12 Dec 1998) |
| infection control nurse | A registered nurse with additional education in the monitoring and prevention of nosocomial infections in the client population in an agency. Synonym: infection control nurse. (05 Mar 2000) |
| infection control practitioners | Physicians or other qualified individuals responsible for implementing and overseeing the policies and procedures followed by a health care facility to reduce the risk of infection to patients and staff. (12 Dec 1998) |
| analytic study | In epidemiology, a study designed to examine associations, commonly putative or hypothesised causal relationships; usually concerned with identifying or measuring the effects of risk factors or with the health effects of specific exposures. (05 Mar 2000) |
| blinded study | Clinical trials of drugs are often done blinded so that the patient does not know (is blinded as to) whether they are receiving the product being tested or the control/placebo to ensure that the results of a study are not affected by a possible placebo effect (by the power of suggestion). (12 Dec 1998) |
| blind study | A study in which the experimenter is unaware of which group is subject to which procedure. (05 Mar 2000) |
| retrospective study | <epidemiology> A study in which people are enrolled and then have their history of risks, infections or disease measured. (05 Dec 1998) |
| rosenzweig picture-frustration study | A projective test depicting cartoon-like characters in frustrating situations. The scoring of the subject's responses indicates the direction of hostility or aggression, that is, whether he blames himself, the other person, or the set of circumstances. (12 Dec 1998) |
| cohort study | A study using epidemiological methods, such as a clinical trial, in which a cohort with a particular attribute (e.g., smokers, recipients of a drug) is followed prospectively and compared for some outcome (e.g., disease, cure) with another cohort not possessing the attribute. (05 Mar 2000) |
| pioped study | <radiology> 251 patients with documented PE on pulmonary angiograms were given V/Q scans: 102 high probability, 105 intermediate probability, 39 low probability, 5 normal or near-normal (12 Dec 1998) |
| multicenter study | A controlled study executed by several cooperating institutions. (12 Dec 1998) |
| multigeneration study | Toxicity test in which at least 3 generations of the test organisms are exposed to the substance being assessed. Exposure is usually continuous. Any medical study which follows a family of people through several generations. (09 Oct 1997) |
| crossover study | <statistics> A study that compares two or more treatments or interventions in which the subjects or patients, upon completion of the course of one treatment, are switched to another. Usually refers to a study in which the subject is switched from the experimental to the control procedure (or vice versa). In the case of two treatments, a and b, half the subjects are randomly allocated to receive these in the order a, b and half to receive them in the order b, a. A criticism of this design is that effects of the first treatment may carry over into the period when the second is given. With this type of study, every patient serves as his or her own control. (21 Jun 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|